Alessio Barilli

Title: Alessio Barilli: Innovator in Pharmaceutical Chemistry

Introduction

Alessio Barilli is a notable inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways.

Latest Patents

Alessio Barilli holds a patent for "Pyridazinyl amino derivatives as ALK5 inhibitors." This invention relates to a compound of general formula (I) that inhibits the transforming growth factor-β (TGF-β) type I receptor (ALK5). The patent outlines methods for preparing these compounds, pharmaceutical compositions containing them, and their therapeutic uses. The compounds may be beneficial in treating diseases or conditions associated with dysregulation of the ALK5 signaling pathway in mammals. He has 1 patent to his name.

Career Highlights

Alessio Barilli is currently employed at Chiesi Farmaceutici S.p.A., a prominent pharmaceutical company. His work focuses on innovative solutions that address critical health challenges through advanced chemical compounds.

Collaborations

Throughout his career, Alessio has collaborated with talented professionals, including Matteo Biagetti and Paolo Ronchi. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Alessio Barilli is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative approach and dedication to research continue to drive advancements in the field.